Virbac

2019 annual revenue shows strong growth of +6.6% at constant exchange rates - Seite 2

The Group’s growth outside the United States was significantly higher at actual exchange rates (+6.2%) and at constant exchange rates (+5.4%). In Europe, revenue surged thanks to an excellent performance at the end of the year resulting in solid annual growth of +5.4% at actual rates (+5.2% at constant rates). The main contributors to this performance were Northern European countries (including Germany and the United Kingdom), France, which achieved strong results in the last quarter, and Spain, which compensated for Italy’s withdrawal. In the Asia Pacific region, growth at actual exchange rates was +5.7% (+4.0% at constant exchange rates). Growth was very strong in China and Japan, with India achieving more moderate growth, whilst, Australia and New Zealand ended the year down compared to 2018. In Latin America, excluding Chile, the business grew by +11.1% at actual exchange rates (+9.7% at constant exchange rates), reflecting strong contributions by Brazil and Mexico. Finally, in Chile, the business achieved healthy growth of +6.7% at actual exchange rates (+4.5% at constant exchange rates), mainly fueled by sales of parasiticides and injectable vaccines for salmon.

In terms of species, revenue in the companion animal segment grew overall by +11.3% at actual rates (+9.5% at constant rates), buoyed by strong performances across all ranges (petfood, dental, specialty, parasiticide). The food producing animal segment showed more moderate growth of +3.4% at actual rates (+2.4% at constant rates). The aquaculture sector grew by +9.1% at constant rates, while the ruminant sector grew by +2.6% at constant rates, thanks to sales of bovine vaccines and food supplements for cattle, and finally, the industrial farming sector (swine and poultry) showed a downturn of -2.4% at constant rates, mainly impacted by new regulations governing the prescription of antibiotics in Italy.

Outlook
In 2019, the ratio of “current operating profit before depreciation of assets arising from acquisitions” to “revenue”, is expected to increase by around 3 points at constant exchange rates compared to 2018 (2.5 points excluding exceptional items). From a financial perspective, rigorous control of capital employed should allow further debt relief of about €80 million at constant rates for the year.

For 2020, the Group anticipates revenue growth at constant rates of between 4% and 6%, and an increase in the ratio of “current operating profit before depreciation of assets arising from acquisitions” to “revenue”, of around 0.5 point at constant exchange rates compared to 2019 (1 point excluding exceptional items).